SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENTSeries C Convertible Preferred Stock Purchase Agreement • March 19th, 2021 • Bardin Hill Investment Partners LP • Natural gas transmisison & distribution • New York
This SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of March 17, 2021 (the “Effective Date”), is entered into by and between NextDecade Corporation, a Delaware corporation (“NextDecade” or the “Company”), and each of the parties set forth on the signature pages hereto under the heading “Purchasers” (the “Purchasers”). NextDecade and the Purchasers are referred to herein individually as a “Party” and collectively as the “Parties.”
SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENTSeries C Convertible Preferred Stock Purchase Agreement • March 29th, 2021 • NextDecade Corp. • Natural gas transmisison & distribution • New York
This SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of March 26, 2021 (the “Effective Date”), is entered into by and between NextDecade Corporation, a Delaware corporation (“NextDecade” or the “Company”), and OGCI Climate Investments Holdings LLP (the “Purchaser”). NextDecade and the Purchaser are referred to herein individually as a “Party” and collectively as the “Parties.”
SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENTSeries C Convertible Preferred Stock Purchase Agreement • May 28th, 2021 • Miromatrix Medical Inc. • Biological products, (no disgnostic substances) • Delaware
THIS SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (this “Agreement”), is made as of May 3, 2021, by and among Miromatrix Medical Inc., a Delaware corporation (the “Company”), and the investors listed on Exhibit A attached to this Agreement (each a “Purchaser” and together the “Purchasers”).
SECTION 3 Representations and Warranties of the CompanySeries C Convertible Preferred Stock Purchase Agreement • November 9th, 1999 • Global Pharmaceutical Corp \De\ • Pharmaceutical preparations • New York
SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENTSeries C Convertible Preferred Stock Purchase Agreement • August 2nd, 2021 • NextDecade Corp. • Natural gas transmisison & distribution • New York
This SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of July 30, 2021 (the “Effective Date”), is entered into by and between NextDecade Corporation, a Delaware corporation (“NextDecade” or the “Company”), and TEP Next Decade, LLC, a Delaware limited liability company (the “Purchaser”). NextDecade and the Purchaser are referred to herein individually as a “Party” and collectively as the “Parties.”
REMOTEMDX, INC. SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENTSeries C Convertible Preferred Stock Purchase Agreement • May 4th, 2007 • Remote MDX Inc • Electronic & other electrical equipment (no computer equip) • Utah
This Agreement, dated as of March __, 2006 is entered into by and among RemoteMDx, Inc., a Utah corporation (the “Company”) and the individual or entity named on the signature page hereto (each an “Initial Purchaser”), and the individuals and entities who become parties to this Agreement after the date hereof in accordance with Section 2.2 hereof by executing a copy of this Agreement (the “Additional Purchasers”). The Initial Purchasers and the Additional Purchasers are collectively referred to as the “Purchasers”. In consideration of the mutual promises and covenants contained in this Agreement, the parties hereto agree as follows:
AMENDMENT NO. 1 TO SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENTSeries C Convertible Preferred Stock Purchase Agreement • April 2nd, 2015 • Collegium Pharmaceutical, Inc • Pharmaceutical preparations
This Amendment No. 1 (this “Amendment”) dated as of September 24, 2013 amends that certain Series C Convertible Preferred Stock Purchase Agreement dated as of August 27, 2013 (the “Purchase Agreement”) by and among Collegium Pharmaceutical, Inc., a Delaware corporation (the “Company”), and the persons and entities listed on Schedule A attached thereto (the “Purchasers”). All capitalized terms used but not defined in this Amendment shall have the meanings assigned to such terms in the Purchase Agreement.
Form of Series C Convertible Preferred Stock Purchase Agreements between the Company and the InvestorsSeries C Convertible Preferred Stock Purchase Agreement • June 9th, 2011 • Vycor Medical Inc • Surgical & medical instruments & apparatus • New York
This SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (the “Agreement”) is dated as of June [__], 2011 by and among Vycor Medical, Inc., a Delaware corporation (the “Company”), and each of the Purchasers of shares of Series C Convertible Preferred Stock of the Company whose names are set forth on Exhibit A hereto (individually, a “Purchaser” and collectively, the “Purchasers”).
EXA CORPORATION SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENTSeries C Convertible Preferred Stock Purchase Agreement • August 3rd, 2011 • Exa Corp • Massachusetts
This SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (the “Agreement”) is made this 30th day of September, 1996 by and among Exa Corporation, a Massachusetts corporation (the “Company”) and Fidelity Ventures Ltd. (“Fidelity”), Fidelity Investors Limited Partnership (“Fidelity Investors”), Boston Capital Ventures III, Limited Partnership (“BCV”), Edelson Technology Partners (“Edelson”), Massachusetts Capital Resource Company (“MCRC”), Associated Group, Inc. (“Associated”), Itochu Corporation, Itochu Techno-Science Corporation, Itochu Technology, Inc., John J. Shields, III and John William Poduska (collectively, the “Investors”).
AMENDMENT NO. 1 TO SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENTSeries C Convertible Preferred Stock Purchase Agreement • March 3rd, 2015 • Collegium Pharmaceutical Inc • Pharmaceutical preparations
This Amendment No. 1 (this “Amendment”) dated as of September 24, 2013 amends that certain Series C Convertible Preferred Stock Purchase Agreement dated as of August 27, 2013 (the “Purchase Agreement”) by and among Collegium Pharmaceutical, Inc., a Delaware corporation (the “Company”), and the persons and entities listed on Schedule A attached thereto (the “Purchasers”). All capitalized terms used but not defined in this Amendment shall have the meanings assigned to such terms in the Purchase Agreement.
EXHIBIT 1 SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT THIS SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT is made as of the 4th day of September, 2003, by and among INSCI Corp., a Delaware corporation (the "Company") and SCP...Series C Convertible Preferred Stock Purchase Agreement • September 12th, 2003 • SCP Private Equity Partners Ii Lp • Services-computer integrated systems design • Delaware
SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENTSeries C Convertible Preferred Stock Purchase Agreement • April 30th, 2004 • Selway Partners LLC • Services-computer integrated systems design • Delaware
THIS SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT is made as of the 31st day of March, 2004, by and among INSCI Corp., a Delaware corporation (the “Company”), Selway Partners, LLC, (“Selway”) and CIP Capital L.P. (“CIP”, and with Selway, the “Investors”).
